8-KShareholder Matters

ABBOTT LABORATORIES 8-K Report, Shareholder Vote Results (May 1, 2012)

Filed May 1, 2012For Securities:ABT

Summary

This 8-K filing reports on Abbott Laboratories' Annual Meeting of Shareholders held on April 27, 2012. The primary focus is on the voting outcomes of various proposals, including the election of directors and the ratification of auditors. For investors, the key takeaway is the overwhelming support for the company's slate of directors and the ratification of Deloitte & Touche LLP as auditors, indicating shareholder confidence in the current leadership and governance structure. The filing also details the results of several shareholder proposals. While the "say-on-pay" vote for executive compensation received strong approval, a significant majority of shareholders rejected several other proposals related to corporate governance, executive compensation disclosures, independent board leadership, and executive stock retention policies. This suggests that while shareholders are generally satisfied with the company's financial oversight and executive compensation, there is a desire for stricter corporate governance practices in specific areas.

Key Highlights

  • 1All of Abbott's nominated directors were elected to the Board of Directors, receiving substantial "For" votes and demonstrating strong shareholder support for current leadership.
  • 2Shareholders overwhelmingly ratified the appointment of Deloitte & Touche LLP as Abbott's independent auditor for the upcoming fiscal year.
  • 3The advisory "say-on-pay" vote regarding the compensation of named executive officers was approved by 91.96% of the votes cast, indicating general satisfaction with executive compensation practices.
  • 4Shareholder proposals concerning transparency in animal research, lobbying policies, independent board chairman, tax gross-up payments, executive stock retention, exclusion of compliance costs from incentive compensation, and accelerated vesting of equity awards were all rejected by a significant margin.
  • 5The rejections of multiple governance-related shareholder proposals suggest that the board's existing policies and practices are largely aligned with the majority shareholder sentiment on these matters.
  • 6A substantial number of broker non-votes (213,186,769) were recorded for director elections and the executive compensation vote, a common occurrence in such meetings.

Frequently Asked Questions

The main outcomes were the election of all nominated directors to the board, the ratification of Deloitte & Touche LLP as the company's auditor, and the approval of the executive compensation plan. Additionally, several shareholder proposals concerning corporate governance and executive compensation were voted down.

Yes, the advisory "say-on-pay" proposal regarding the compensation of Abbott's named executive officers was approved by approximately 91.96% of the votes cast. This indicates general shareholder confidence in the company's executive compensation structure.

All shareholder proposals, which covered topics such as transparency in animal research, lobbying disclosures, independent board chairman, executive compensation policies (tax gross-ups, stock retention, exclusion of compliance costs, accelerated vesting), were rejected by a significant majority of shareholders. This suggests that the board's current policies are favored by the majority of voters.

The election of the Board of Directors received very strong support. For example, Robert J. Alpern, M.D. received over 1.14 billion "For" votes, with a significantly lower number of "Withheld" votes and broker non-votes. All nominated directors were elected.